Methylene Blue 10mg

Common questions about Methylene Blue 10mg

What is methylene blue?

Methylene blue is a synthetic phenothiazine dye that has been used in medicine since the 1890s, originally as a malaria treatment and later as an FDA-approved drug for methemoglobinemia. It is a small molecule with documented activity at the mitochondrial electron transport chain, where it acts as an alternative electron carrier and supports ATP production under conditions of mitochondrial stress. The methylene blue capsule Optimal Balance Pharmacy compounds for PeptideRx prescriptions is a 10 mg capsule at $2 per capsule with a $39 medical visit fee.

What does methylene blue do for cognition and mitochondrial function?

Methylene blue donates electrons to complex IV of the mitochondrial electron transport chain, supporting ATP production when standard electron flow is impaired. Animal and limited human data show neuroprotective effects in models of cognitive decline, improved memory in low doses, and antioxidant activity through cycling between reduced and oxidized forms. Most clinical use is for cognitive support, post-concussion recovery, and as an adjunct in select neurodegenerative protocols. Effects on cognition are typically reported within hours to days at low oral doses.

How much methylene blue should I take per day?

The PeptideRx 10 mg capsule (mb-10) is the standard nootropic dose for adults who have already established tolerance at a lower dose (5 mg or below). Higher doses (15 mg and 25 mg) are available for established users only. Doses above 100 mg per day enter pharmacological territory and require clinical supervision. Take with water on an empty stomach, typically once daily in the morning. Your provider sets the dose per your tolerance and goals.

Is methylene blue safe?

Pharmaceutical-grade methylene blue at low oral doses (under 50 mg per day) has a strong safety record over more than a century of clinical use. Common transient effects include blue or green discoloration of urine and tongue and rare mild GI upset. Methylene blue is a monoamine oxidase inhibitor (MAOI) at higher doses, which creates a serious serotonin-syndrome risk if combined with SSRIs, SNRIs, MAOIs, or other serotonergic medications. PeptideRx automatically denies methylene blue to patients on any of those medications and to anyone with G6PD deficiency.

How does methylene blue work?

At low doses methylene blue acts as a redox shuttle in the mitochondrial electron transport chain, accepting and donating electrons between complexes and supporting ATP production when standard flow is impaired. It also has antioxidant properties through its reduction-oxidation cycling and binds to amyloid plaques and tau aggregates in laboratory models. At higher doses (above ~50 mg) it inhibits monoamine oxidase, which is the basis for the SSRI/SNRI contraindication.

What are the documented benefits of methylene blue?

Documented or studied uses include: clinical treatment of methemoglobinemia (FDA-approved indication), cognitive support and memory in animal models, neuroprotection in models of stroke and neurodegeneration, photodynamic therapy as an antimicrobial agent, and adjunctive use in some malaria protocols. Cognitive enhancement at low doses is widely reported by users but human trial data on cognitive endpoints is still limited. Use under provider supervision to ensure dose, source, and contraindication screening are correct.

What medications cannot be combined with methylene blue?

Do not combine methylene blue with SSRIs (sertraline, fluoxetine, escitalopram, etc.), SNRIs (venlafaxine, duloxetine), MAOIs, tricyclic antidepressants, lithium, tramadol, dextromethorphan, or any other serotonergic medication. The combination can cause serotonin syndrome, which is potentially life-threatening. Patients with G6PD deficiency must not take methylene blue at any dose. PeptideRx providers screen for all of these during intake; if any apply, the prescription is automatically denied.